Stocks and Investing
Stocks and Investing
Mon, April 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Seamus Fernandez Downgraded (ALT) to Hold on, Apr 29th, 2024
Seamus Fernandez of Guggenheim, Downgraded "Altimmune, Inc." (ALT) to Hold on, Apr 29th, 2024.
Seamus has made no other calls on ALT in the last 4 months.
There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Seamus's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024
These are the ratings of the 2 analyists that currently disagree with Seamus
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Monday, April 1st, 2024
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024
Contributing Sources